Completed
The Determinants of the Biology of HIV Transmission to Determine the Immunologic and Virologic Characteristics of Those Who May Have Transmitted HIV to Another Individual
Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2015-10-22
20
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to look at the amount of HIV in the blood, genital fluid, and saliva of the partners of patients with early HIV infection. This study will also look at the strength of the immune systems of patients with early HIV infection. Because HIV multiplies very quickly in the early stages of infection, patients with early HIV infection may be more likely to transmit HIV to their partners. The amount of HIV in blood, genital fluid, and saliva may determine the risk for transmission.
CONDITIONS
Brief Title
The Biology of HIV Transmission
Who Can Participate
Eligibility Criteria
Inclusion Criteria
Patients may be eligible for this study if they:
- Are at least 18 years old.
- Have sex with or share injection drugs with a person who is thought to have early HIV infection, or if they have recently become HIV-positive.
- Can provide written consent.
- Are available for a follow-up period of at least 4 weeks.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here